DESONEX desloratadine 5 mg tablet film coated blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

desloratadine, Quantity: 5 mg

Commercializzato da:

Bayer Australia Ltd

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: maize starch; purified water; Carnauba Wax; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; purified talc; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; macrogol 400

Via di somministrazione:

Oral

Confezione:

2,3,5,7,10,14,15,20,25,28,30,42,45,50,60, 4, 1 tablet (sample pack), 40

Tipo di ricetta:

(S2) Pharmacy Medicine

Indicazioni terapeutiche:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinitis include rhinorrhoea, sneezing and nasal,itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of,symptoms associated with perennial allergic rhinitis. The symptomatic relief of itching and reduction in the size and number of hives associated with,chronic idiopathic urticaria.

Dettagli prodotto:

Visual Identification: Light blue round, central circular debossed on one side of the tablet, plain on the other side, film-coated tablets; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2021-01-05